February 6 – 9, 2025| Lake Tahoe, CA
Please claim your credit by February 28, 2025.
Activity Overview
Each year The California Pacific Society of Facial Plastic Surgery invites leaders in the world of aesthetic surgery to gather in California to share
new techniques, emerging trends, pearls of wisdom and insight. The 2025 winter meeting promises to deliver an outstanding experience for all
attendees as our expert multi-disciplinary faculty brings advanced and interesting lectures and workshops in an intimate learning environment.
Target Audience
This activity has been designed to meet the educational needs of those Board Certified or Board Eligible in Plastic Surgery, Facial Plastic Surgery, Dermatology, and Oculoplastic Surgery, Aesthetic Injectors and Allied Health Professionals working directly with one of those specialists such as Registered Nurses and Physicians Assistants.
Learning Objectives
Upon completion of the educational activity, participants should be able to:
- Diagnose skin conditions and compare options for skin rejuvenation through the use of lasers, skin tightening devices, fillers, injectables, and other minimally invasive techniques.
- Apply various face lifting techniques as they relate to anatomy of the patient.
- Identify procedures, surgical vs non-surgical, that would be most beneficial to the presenting patient.
- Demonstrate an improved understanding of how to avoid common problems with Rhinoplasty.
- Differentiate the various approaches to blepharoplasty and brow lifting.
- Discuss utilizations and limitations of injectable fillers and non-invasive devices.
- Evaluate controversial topics in facial aesthetic surgery for more informed decisions as related to patient outcomes.
Criteria for Success
Statements of credit will be awarded based on the participant’s attendance and will be available upon completion of an online evaluation/claim
credit form available at:
Please claim your credit by February 28, 2025.
CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and The California Society of Facial Plastic Surgery (CSFPS). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 26.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
Credit being awarded: 26.75 ANCC contact hours
Physician Associate
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 26.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and The California Society of Facial Plastic Surgery (CSFPS). AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 22.75 contact hour(s) (which includes 5.5 hour(s) of pharmacology).
Commercial Support
At time of print: This activity is supported by an independent medical education grant from AbbVie Inc., Evolus Medical Affairs, and Merz North America, Inc. This activity received in-kind support from AbbVie Inc., Evolus Medical Affairs, Merz North America, Inc., Prollenium, and Revance Therapeutics, Inc.
| DISCLOSURES | ||
| Name | Relationship | Commercial Interest |
| Corey Maas, MD (chairman/faculty) | Advisor | Abbvie; Chroma Pharma; Evolus; Galderma; Merz |
| Consultant | Abbvie; Evolus; Galderma; Merz | |
| Independent contractor; Researcher; Speaker | Abbvie; Galderma; Merz | |
| James Newman, MD (chairman/faculty/moderator) | N/A | Nothing to disclose |
| Chloe Belteau, MD (faculty) | N/A | Nothing to disclose |
| Ritu Chopra, MD (faculty) | N/A | Nothing to disclose |
| Josh DeBlasio (faculty/moderator) | N/A | Nothing to disclose |
| Deedee Crossett (faculty) | N/A | Nothing to disclose |
| Peter Eskander, BS, MD (faculty) | N/A | Nothing to disclose |
| Andrew Frankel, MD (faculty; moderator) | Executive role; Individual stocks and stock options | BEMY Cosmetics, Inc. |
| Nima Gharavi, MD (faculty) | N/A | Nothing to disclose |
| Mohsen Ghoreishi (faculty) | N/A | Nothing to disclose |
| Michael Glafkides, MD (faculty) | N/A | Nothing to disclose |
| Anna Guanche, MD (faculty) | N/A | Nothing to disclose |
| Brian Hayes (faculty) | N/A | Nothing to disclose |
| Emelia Hughes, MD (faculty) | N/A | Nothing to disclose |
| Graham Ives, MD (faculty) | N/A | Nothing to disclose |
| Ramtin Kassir, MD (faculty) | N/A | Nothing to disclose |
| Sheila Kassir, MD (faculty) | N/A | Nothing to disclose |
| Gregory Keller, MD (faculty) | Advisor; Ownership interest | MediCell |
| Steve Lee, MD (faculty) | N/A | Nothing to disclose |
| Catherine Maley, MBA (faculty) | N/A | Nothing to disclose |
| Marc Mani, MD (faculty) | N/A | Nothing to disclose |
| Umang Mehta, MD (faculty) | N/A | Nothing to disclose |
| Amir Moradi, MD (faculty; moderator) | Advisor | AbbVie; Evolus; Galderma; GloPharma; Merz Aesthetics; Skin Medica; Symatese; Teoxane |
| Consultant | AbbVie; Alastin; Evolus; Galderma; GloPharma; Merz Aesthetics; Skin Medica; Symatese; Teoxane | |
| Individual stocks and stock options | Evolus; Glopharma | |
| Researcher | AbbVie; Alastin; Evolus; Galderma; GloPharma; L’Oréal; Merz Aesthetics; Skin Better; Skin Medica; Skinceuticals; Symatese; Teoxane; Veradermics | |
| Serena Mraz, MD (faculty) | N/A | Nothing to disclose |
| Melanie Palm, MD (faculty) | Advisor | Abbvie; BTL; EltaMD; Galderma; Revision |
| Ownership interest | Invo Aesthetics | |
| Researcher | Abbvie; BTL; Galderma; Revision | |
| Speaker | BTL; Galderma; Revision | |
| Sam Peek, MD (faculty) | N/A | Nothing to disclose |
| Debra Phairas (faculty) | N/A | Nothing to disclose |
| Jason Roostaeian, MD (faculty) | N/A | Nothing to disclose |
| Jacob Sedgh, MD (faculty) | N/A | Nothing to disclose |
| Stuart Seiff, MD (faculty; moderator) | Consultant | Matrix Surgical; Roche; Tourmaline Bio |
| Mona Sharif, MA (faculty) | N/A | Nothing to disclose |
| Ruth Swissa, CMM (faculty) | N/A | Nothing to disclose |
| Stan Tolkachjov, MD (faculty) | Researcher; Speaker | BI; Castle Biosciences; Kerecis |
| Lisa Marie Wark (faculty) | N/A | Nothing to disclose |
| Edwin Williams, MD (faculty) | N/A | Nothing to disclose |
| Chim Yang, MD (faculty) | N/A | Nothing to disclose |
| Kamakshi Zeidler, MD (faculty) | Advisor; Consultant; Ownership Interest | Bimini; Establishment Labs; Integra; Lumisque |
| Dorothy Caputo, MA, BSN, RN – President, AKH Inc | N/A | Nothing to disclose |
| Bernadette Makar, MSN, APRN-BC, NP-C (planner/reviewer) | N/A | Nothing to disclose |
| Michele Bielarski, RN (planner/reviewer) | N/A | Nothing to disclose |
| AKH Inc Staff and Planners | N/A | Nothing to disclose |
| CSFPS Staff and Planners | N/A | Nothing to disclose |
| All of the relevant financial relationships listed for these individuals have been mitigated. | ||
Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with “Opt Out” in the subject line.
